(Q45286756)

11 December 2017

Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study (English)

1 reference

amyotrophic lateral sclerosis

11 December 2017

0 references

1 reference

1

1 reference

11 December 2017

9

Patrick Weydt

1 reference

11 December 2017

Michael D Weiss

2

1 reference

11 December 2017

Jau-Shin Lou

3

1 reference

11 December 2017

Mark P Jensen

4

1 reference

11 December 2017

R Ted Abresch

5

1 reference

11 December 2017

Tara K Martin

6

1 reference

11 December 2017

Thomas W Hecht

7

1 reference

11 December 2017

Jay J Han

8

1 reference

11 December 2017

George H Kraft

10

1 reference

11 December 2017

1 January 2005

1 reference

American Journal of Hospice and Palliative Medicine

11 December 2017

1 reference

11 December 2017

22

1 reference

11 December 2017

1

1 reference

11 December 2017

55-59

1 reference

Practice parameter: The care of the patient with amyotrophic lateral sclerosis (An evidence-based review).

11 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Fatigue and depression are associated with poor quality of life in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

A cross sectional study on determinants of quality of life in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Quality of Life in Patients with Amyotrophic Lateral Sclerosis: Perceptions, Coping Resources, and Illness Characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Correlates of suffering in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Role of fatigue in limiting physical activities in humans with neuromuscular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Dissociation between mechanical and myoelectrical manifestation of muscle fatigue in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Central fatigue during isometric exercise in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Physiology of fatigue in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Electrical and mechanical properties of skeletal muscle underlying increased fatigue in patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Current pharmacological management of amyotrophic [corrected] lateral sclerosis and a role for rational polypharmacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Modafinil for excessive daytime sleepiness in myotonic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Successful treatment of excessive daytime sleepiness in Parkinson's disease with modafinil

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Modafinil for fatigue in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Modafinil prevents glutamate cytotoxicity in cultured cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Electroencephalographic effects of modafinil, an alpha-1-adrenergic psychostimulant, on the sleep of rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Modafinil increases histamine release in the anterior hypothalamus of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Functional magnetic resonance imaging neuroactivation studies in normal subjects and subjects with the narcoleptic syndrome. Actions of modafinil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

The reliability of a self-reported measure of disease, impairment, and function in persons with spinal cord dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

Onset, natural history and outcome in idiopathic adult motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

The natural history of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910502200112

10.1177/104990910502200112

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference